Industry NewsFDA approves NGS-based companion diagnostic for previously treated IDH1-mutated cholangiocarcinoma
Industry NewsQIAGEN receives FDA authorization for rapid portable test that can analyze over 30 samples per hour for SARS-CoV-2 antigen